Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation

V Borges, JP Gomes - Infection, Genetics and Evolution, 2015 - Elsevier
Lymphogranuloma venereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1–L3). LGV clinical …
被引用次数：27 相关文章

Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation

V Borges, JP Gomes - Evolutionary dynamics of Chlamydia …, 2015 - search.proquest.com
Lymphogranuloma verereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1 to L3). LGV clinical …

Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation.

V Borges, JP Gomes - Infection, Genetics and Evolution: Journal of …, 2015 - europepmc.org
Lymphogranuloma venereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1-L3). LGV clinical …

Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation

V Borges, JP Gomes - Infection, Genetics and Evolution, 2015 - repositorio.insa.pt
Lymphogranuloma venereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1-L3). LGV clinical …
[PDF] unl.pt

[PDF][PDF] Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation

V Borges, JP Gomes - … dynamics of Chlamydia trachomatis genome and …, 2015 - run.unl.pt
Lymphogranuloma verereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1 to L3). LGV clinical …

Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation

V Borges, JP Gomes - Infection, genetics and evolution …, 2015 - pubmed.ncbi.nlm.nih.gov
Lymphogranuloma venereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1-L3). LGV clinical …

Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation

V Borges, JP Gomes - Infection, Genetics and Evolution, 2015 - infona.pl
Lymphogranuloma venereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1–L3). LGV clinical …
[PDF] core.ac.uk

[PDF][PDF] Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation

V Borges, JP Gomes - … dynamics of Chlamydia trachomatis genome and …, 2015 - core.ac.uk
Lymphogranuloma verereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1 to L3). LGV clinical …

Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation

V Borges, JP Gomes - Infection, Genetics and Evolution, 2015 - infona.pl
Lymphogranuloma venereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1–L3). LGV clinical …

Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation

V Borges, JP Gomes - Evolutionary dynamics of Chlamydia …, 2015 - search.proquest.com
Lymphogranuloma verereum (LGV) is a human sexually transmitted disease caused by the
obligate intracellular bacterium Chlamydia trachomatis (serovars L1 to L3). LGV clinical …